Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysisSilvio Matsas, Auro del Giglio, Pedro Nazareth Aguiar|Journal of Gastrointestinal Oncology|2024Cited by 22
Evidence Strength of Pharmaceutical Industry-Funded Clinical Trials in Metastatic NSCLC: A Comparison With Other Sources of FundingBárbara de Souza Gutierres, Auro del Giglio, Alanda L. Alves et al.|Journal of Thoracic Oncology|2020Cited by 9
Prognostic role of platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in advanced gastric cancer treated with immunotherapy: A systematic review and meta-analysis.Silvio Matsas, Auro del Giglio, Pedro Nazareth Aguiar|Journal of Clinical Oncology|2024Cited by 7